News
Cancer Researchers ID 'Achilles Heel' of Drug-Resistant Tumors
UC San Francisco scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies. In the process, they devised a new two-pronged approach that yields an effective treatment for these cancers in the laboratory and holds tremendous promise for
New Method Of Breast Reconstruction May Reduce Pain For Some Cancer Survivors
Hani Sbitany, MD, a plastic and reconstructive surgeon at UCSF Health, performs a breast reconstruction surgery. Sbitany is one of a few surgeons using a procedure that is less invasive and has a less painful recovery. Photo by Susan Merrell For nearly four decades, the main option for breast
Small Molecule Discovery Core combines high-throughput biology and medicinal chemistry to accelerate drug discovery
The goal of the Small Molecule Discovery Core (SMD) is to help the Cancer Center and other investigators initiate drug discovery and chemical biology projects for their most innovative and exciting new targets. Faculty co-directors Adam Renslo, PhD and Michelle Arkin, PhD, both of UCSF’s
New 'SLICE' Tool Can Massively Expand Immune System's Cancer-Fighting Repertoire
Immunotherapy can cure some cancers that until fairly recently were considered fatal. In addition to developing drugs that boost the immune system’s cancer-fighting abilities, scientists are becoming expert at manipulating a patient’s own immune cells, turning them into cancer-killing armies. But
Get To Know: Tung Nguyen, MD
Dr. Tung Nguyen is the Stephen J. McPhee, MD Endowed Chair in General Internal Medicine and Professor of Medicine at the University of California, San Francisco (UCSF). A general internist with a large panel of Asian American patients, Dr. Nguyen teaches medical students and residents about medicine
Less Surveillance Needed for Simple Ovarian Cysts
Simple ovarian cysts are extremely common in women and do not require additional ultrasound surveillance or surgical removal, according to a new study of more than 72,000 women and close to 119,00 pelvic ultrasound exams over a dozen years. The study, a collaboration between UC San Francisco and
Cognitive Decline After Radiation Therapy for Brain Tumors Might Be Prevented By Temporarily Shutting Down Immune Response
Treating brain tumors comes at a steep cost, especially for children. More than half of patients who endure radiation therapy for these tumors experience irreversible cognitive decline, a side-effect that has particularly damaging consequences for younger patients. Up to now, scientists had been